Neuroleptic malignant syndrome variant in a patient receiving donepezil and olanzapine

被引：0

作者：

Tanya C Warwick

Venkata Moningi

Prasuna Jami

Kristy Lucas

Ogochukwu Molokwu

Shalini Moningi

机构：

[1] TC Warwick is Assistant Clinical Professor of Neurology at the University of California San Francisco,

[2] Fresno,undefined

[3] CA,undefined

[4] V Moningi is Clinical Assistant Professor of Medicine,undefined

[5] K Lucas is Associate Professor of Pharmacy and Internal Medicine,undefined

[6] and S Moningi is an undergraduate student and Research Assistant at West Virginia University,undefined

[7] Charleston,undefined

[8] WV,undefined

[9] ,undefined

[10] P Jami is an Endocrinology Fellow at the University of Louisville,undefined

[11] KY,undefined

[12] O Molokwu is Assistant Clinical Professor at the School of Pharmacy,undefined

[13] University of California San Francisco,undefined

[14] CA,undefined

[15] USA.,undefined

来源：

Nature Clinical Practice Neurology | 2008年 / 4卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

This Case Study describes a 78-year-old man with a pre-existing parkinsonian syndrome who experienced an adverse drug reaction following administration of an antipsychotic in combination with a cholinesterase inhibitor. The patient was diagnosed with a variant of neuroleptic malignant syndrome.

引用

页码：170 / 174

页数：4

共 50 条

[1] Neuroleptic malignant syndrome variant in a patient receiving donepezil and olanzapine
Warwick, Tanya C.
Moningi, Venkata
Jami, Prasuna
Lucas, Kristy
Molokwu, Ogochukwu
Moningi, Shalini
NATURE CLINICAL PRACTICE NEUROLOGY, 2008, 4 (03): : 170 - 174
[2] Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy
Stevens, Debra L.
Lee, Matthew R.
Padua, Yolanda
PHARMACOTHERAPY, 2008, 28 (03): : 403 - 405
[3] OLANZAPINE INDUCED NEUROLEPTIC MALIGNANT SYNDROME IN AN ICU PATIENT
Willett, Kristine
Durand, Cherlyl
Sanford, Mary
CRITICAL CARE MEDICINE, 2009, 37 (12) : A533 - A533
[4] Olanzapine and neuroleptic malignant syndrome
Tofler, I
PSYCHOSOMATICS, 2002, 43 (06) : 505 - 506
[5] Neuroleptic malignant syndrome and olanzapine
Sierra-Biddle, D
Herran, A
Diez-Aja, S
Gonzalez-Mata, JM
Vidal, E
Diez-Manrique, F
Vazquez-Barquero, JL
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (06) : 704 - 705
[6] Neuroleptic malignant syndrome induced by donepezil
Matsumoto, T
Kawanishi, C
Isojima, D
Iseki, E
Kishida, I
Kosaka, K
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (01): : 101 - 103
[7] DONEPEZIL INDUCED NEUROLEPTIC MALIGNANT SYNDROME
Kalita, Angshuman
Kumar, Anil
INDIAN JOURNAL OF PSYCHIATRY, 2019, 61 (09) : S564 - S564
[8] Suspected neuroleptic malignant syndrome in a patient receiving clozapine
Ganelin, L
Lichtenberg, PS
Marcus, EL
Munter, G
ANNALS OF PHARMACOTHERAPY, 1996, 30 (03) : 248 - 250
[9] Olanzapine induced neuroleptic malignant syndrome
Patra, Bichitra Nanda
Khandelwal, Sudhir K.
Sood, Mamta
INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 (01) : 98 - 99
[10] Neuroleptic malignant syndrome associated to olanzapine
López, MMG
Ciprés, L
de Cendra, E
Franch, JV
MEDICINA CLINICA, 1999, 113 (06): : 239 - 239

← 1 2 3 4 5 →